To test directly whether Perp deficiency promotes mammary cancer development in vivo, we used a mouse mammary cancer model, in which the tumor suppressor p53 is conditionally inactivated in the mammary epithelium through use of a keratin 14 (K14)-Cre transgene. The gene discussed is TP53; the disease is breast cancer.